journal article·2019Open access

Ultralong tumor retention of theranostic nanoparticles with short peptide-enabled active tumor homing

Lihua Li, Yao Lu, Zefeng Lin, Angelina S. Mao, Ju Jiao, Ye Zhu, Chunyan Jiang, Zhongmin Yang, Mingying Peng, Chuanbin Mao

Materials Horizons· Volume 6· Issue 9

Abstract

-Gd/DOXNPs could home to and penetrate deep into the tumors with the unexpected ultralong retention of at least 14 days (as determined by CT/MRI imaging) and the tumor retention half-life of 104.5 h (as determined by ICP-MS analysis) under the guidance of the AR peptide. These NPs can be further used to image tumors with significantly increased sharp contrasts via both CT and MRI, which are much better than the commercial standard contrast agents; moreover, they significantly inhibit tumor growth via the synergistic action of both Bi-enabled photothermal therapy and DOX-induced chemotherapy. The NPs are cleared by the spleen, liver and kidney and then excreted from the body along with faeces and urine. The precise tumor targeting and ultralong tumor retention of these unique NPs would enable both precise tumor detection for early diagnosis and signal-persistent tumor tracking for monitoring the treatment with only a single injection of these NPs.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Luminescent Materials and Devices, and Guangdong Provincial Key Laboratory of Fiber Laser Materials and Applied Techniques

School of Physics

School of Materials Science and Engineering

South China University of Technology

Guangzhou 510641

Department of Orthopedics

Zhujiang Hospital

Southern Medical University

Guangzhou

China

Guangdong Key Lab of Orthopedic Technology and Implant

Guangzhou General Hospital of Guangzhou Military Command

Norman North High School

Norman

USA

Department of Nuclear Medicine

The Third Affiliated Hospital of Sun Yat-Sen University

Department of Chemistry and Biochemistry

Stephenson Life Sciences Research Center

Institute for Biomedical Engineering

Science and Technology

University of Oklahoma

Funding

National Natural Science Foundation of China · National Institutes of Health

References (45)

Show source-provided references
1. Yang · Chem · 2018 · 4 · 128410.1016/j.chempr.2018.02.012 ↗
2. Liu · Nat. Commun. · 2017 · 8 · 1564610.1038/ncomms15646 ↗
3. Liu · Adv. Funct. Mater. · 2016 · 20 · 869410.1002/adfm.201603084 ↗
4. Meyers · Am. J. Roentgenol. · 2007 · 193 · W152
5. Choi · J. Comput. Assist. Tomogr. · 2001 · 25 · 77710.1097/00004728-200109000-00018 ↗
6. Gangi · Am. J. Roentgenol. · 2004 · 182 · 89710.2214/ajr.182.4.1820897 ↗
7. Kobayashi · NPG Asia Mater. · 2015 · 7 · e20310.1038/am.2015.77 ↗
8. Kim · Adv. Funct. Mater. · 2017 · 27 · 160421310.1002/adfm.201604213 ↗
9. Xu · Nanoscale · 2017 · 9 · 462010.1039/C7NR01064H ↗
10. Liu · ACS Nano · 2016 · 12 · 696
11. Lei · Adv. Funct. Mater. · 2017 · 27 · 170201810.1002/adfm.201702018 ↗
12. Mao · ACS Nano · 2016 · 10 · 1114510.1021/acsnano.6b06067 ↗
13. Mjos · Chem. Rev. · 2014 · 114 · 454010.1021/cr400460s ↗
14. Li · Adv. Funct. Mater. · 2018 · 28 · 170462310.1002/adfm.201704623 ↗
15. Detappe · Nano Lett. · 2017 · 17 · 173310.1021/acs.nanolett.6b05055 ↗
16. Wu · Biomaterials · 2047 · 159 · 3710.1016/j.biomaterials.2017.12.022 ↗
17. Yang · Chem. Rev. · 2017 · 117 · 1037710.1021/acs.chemrev.7b00100 ↗
18. Huang · Biomaterials · 2012 · 33 · 437010.1016/j.biomaterials.2012.02.060 ↗
19. He · J. Mater. Chem. B · 2017 · 5 · 249110.1039/C6TB02650H ↗
20. Xia · ACS Appl. Mater. Interfaces · 2018 · 10 · 1708110.1021/acsami.8b03861 ↗
21. Lin · Chem. Sci. · 2019 · 10 · 121910.1039/C8SC04363A ↗
22. Qu · NPG Asia Mater. · 2017 · 9 · e45210.1038/am.2017.196 ↗
23. Qu · NPG Asia Mater. · 2017 · 9 · e45210.1038/am.2017.196 ↗
24. Anderson · Chem. Mater. · 2016 · 28 · 494510.1021/acs.chemmater.6b01225 ↗
25. Kanezashi · Chem. Commun. · 2010 · 46 · 617110.1039/c0cc01461c ↗
26. Daigoku · Chem. Phys. Lett. · 2006 · 430 · 22110.1016/j.cplett.2006.09.004 ↗
27. Wojtkowiak · Mol. Pharmaceutics · 2011 · 8 · 203210.1021/mp200292c ↗
28. Torchilin · Nat. Rev. Drug Discovery · 2014 · 13 · 81310.1038/nrd4333 ↗
29. Chen · ACS Appl. Mater. Interfaces · 2013 · 5 · 728210.1021/am401627u ↗
30. Shilo · Nanomedicine · 2012 · 7 · 25710.2217/nnm.11.190 ↗
31. Lee · Adv. Mater. · 2013 · 25 · 264110.1002/adma.201300081 ↗
32. Torchilin · Adv. Drug Delivery Rev. · 2011 · 63 · 13110.1016/j.addr.2010.03.011 ↗
33. Bertrand · Adv. Drug Delivery Rev. · 2014 · 66 · 210.1016/j.addr.2013.11.009 ↗
34. Wang · Adv. Mater. · 2016 · 28 · 895010.1002/adma.201603114 ↗
35. Jaque · Nanoscale · 2014 · 6 · 949410.1039/C4NR00708E ↗
36. Xu · Cell. Mol. Immunol. · 201810.1038/s41423-018-0184-y ↗
37. Chu · Nat. Rev. Cancer · 2014 · 14 · 19910.1038/nrc3672 ↗
38. Sun · Angew. Chem., Int. Ed. · 2014 · 53 · 1232010.1002/anie.201403036 ↗
39. Sulheim · J. Controlled Release · 2018 · 279 · 29210.1016/j.jconrel.2018.04.026 ↗
40. Haley · Urol. Oncol. · 2008 · 26 · 5710.1016/j.urolonc.2007.03.015 ↗
41. Lu · Small · 2010 · 6 · 179410.1002/smll.201000538 ↗
42. Peng · Nat. Nanotechnol. · 2019 · 14 · 27910.1038/s41565-018-0356-z ↗
43. Peng · ACS Appl. Mater. Interfaces · 2018 · 10 · 3193810.1021/acsami.8b10527 ↗
44. Wang · Chem. Mater. · 2018 · 30 · 375910.1021/acs.chemmater.8b00840 ↗
45. Setyawati · Nat. Commun. · 2013 · 4 · 167310.1038/ncomms2655 ↗